Oxford Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-111,706
| Closed | -$659K | – | 1473 |
|
|
2019
Q4 | $659K | Buy |
111,706
+45,120
| +68% | +$266K | 0.02% | 1091 |
|
|
2019
Q3 | $353K | Sell |
66,586
-28,078
| -30% | -$149K | 0.01% | 1403 |
|
|
2019
Q2 | $729K | Buy |
94,664
+15,101
| +19% | +$116K | 0.02% | 1115 |
|
|
2019
Q1 | $1.58M | Buy |
79,563
+70,691
| +797% | +$1.41M | 0.03% | 694 |
|
|
2018
Q4 | $117K | Buy |
+8,872
| New | +$117K | ﹤0.01% | 1633 |
|
|
2016
Q3 | – | Sell |
-57,387
| Closed | -$3.25M | – | 883 |
|
|
2016
Q2 | $3.25M | Buy |
+57,387
| New | +$3.25M | 0.11% | 252 |
|